Okayama University Seeks Approval for Innovative Cancer Treatment with Oncolytic Virus Therapy Okayama University has applied for regulatory approval of Telomerase, a groundbreaking oncolytic virus treatment for esophageal cancer, potentially transforming patient care in Japan.

Okayama University Seeks Approval for Innovative Cancer Treatment with Oncolytic Virus Therapy #Okayama_University #Telomerase #Oncolys_Biopharma